00:28, 28 февраля 2026Мир
�@�܂��t��HD�Ή����f����MED-PL2K103��VESA�}�E���g���T�|�[�g���Ă����A�Ή������e���r�w�ʂȂǂւ̎����t�����\���B
。PDF资料对此有专业解读
Globally, Reebok's business has shown signs of recovery. Financial statements from Reebok International Limited show net profit rising from $164 million in 2023 to $180 million in 2024.
GLP-1 drugs have not been approved for addiction, and there is not yet enough evidence to prescribe them solely for that purpose. But for millions of people already weighing whether to start a GLP-1 drug for diabetes, obesity or another approved indication, it is one more factor worth considering.